NORMAS PARA LA PRESENTACIÓN DE RESÚMENES
Resúmenes aprobados:
| ID | Título | Submetedor |
| 25040 | THE IMPORTANCE OF SIMULATED PATIENT IN PHARMACEUTICAL CARE EDUCATION: AN EXPERIENCE REPORT | LUDMILA ROSARIO CAMPOS |
| 25038 | EVALUATION OF PHARMACY STUDENTS’ KNOWLEDGE ABOUT HIV AT A PUBLIC UNIVERSITY IN SOUTHEAST BRAZIL | MARIA CLARA SILVA DOS SANTOS |
| 25035 | HEALTH EDUCATION FOR THE PROMOTION OF RATIONAL USE OF PSYCHOACTIVE DRUGS: A UNIVERSITY EXTENSION EXPERIENCE | THAYNARA MARIA CANAL SILVA |
| 25034 | FACTORS ASSOCIATED WITH KNOWLEDGE OF PEOPLE LIVING WITH HIV ATTENDED AT A DISPENSING FACILITY IN THE SOUTHEAST OF BRAZIL | LAURA CANDEIAS DOS SANTOS |
| 25033 | OUTCOMES BEYOND INFECTION MANAGEMENT IN COMPREHENSIVE MEDICATION MANAGEMENT SERVICES FOR PEOPLE LIVING WITH HIV | ANA LUDMILA SANTOS PLAUSKA |
| 25032 | PROJECT-BASED LEARNING IN TEACHING IN EPIDEMIOLOGY: THE PERSPECTIVE OF TWO POSTGRADUATE STUDENTS | LARISSA COUTO ROSA |
| 25031 | DEVELOPMENT AND VALIDATION OF EDUCATIONAL MATERIALS ON HIV | RENATA BRAGA CORDEIRO |
| 25029 | PROJECT-BASED LEARNING IN TEACHING IN EPIDEMIOLOGY: THE PERSPECTIVE OF A PHARMACY GRADUATE | JOAO LUCAS BRAGA PERIN |
| 25028 | PUERICULTURA NAS UNIDADES DE SAÚDE DE VENDA NOVA DO IMIGRANTE: ESTRATÉGIA DE CUIDADO A ANEMIA POR DEFICIÊNCIA DE FERRO. | BEATRIZ DELBEM FIORESE |
| 25025 | INSTA-PHARMA: LEVERAGING INSTAGRAM FOR SCIENCE COMMUNICATION AND PHARMACEUTICAL CARE | BÁRBARA BRAMBILA MANSO |
| 25024 | CASE REPORT: SUSPECTED HEPATOCELLULAR DAMAGE CAUSED BY QUETIAPINE, IDENTIFIED DURING PHARMACOTHERAPEUTIC FOLLOW-UP | SARAH MAGALHÃES RIBEIRO MATA |
| 25023 | ASSESSMENT OF THE RISKS ASSOCIATED WITH THE MISUSE OF PROTON PUMP INHIBITORS | RENILDA SOUSA DE FREITAS |
| 25021 | EPIDEMIOLOGICAL PROFILE OF MEDICATION POISONING IN THE NORTHERN REGION OF BRAZIL IN 2023 | DELMIRA DA SILVA BARRAL |
| 25020 | CASPASE-3 ACTIVATION, APOPTOSIS EFFECTOR PROTEIN, IN SH-SY5Y CELLS EXPOSED BY ASSOCIATION BETWEEN KETAMINE AND ETHANOL OCCURS IMMEDIATELY AFTER EXPOSURE | GIULIA DE ASSIS BRAZ |
| 25019 | INTERPROFESSIONAL COLLABORATION FROM THE PERSPECTIVE OF HEALTHCARE PROFESSIONALS PARTICIPATING IN THERAPEUTIC PHARMACY COMMITTEES | RAIANE LUZIA MARCAL |
| 25018 | SHARING KNOWLEDGE ABOUT FUNCTIONAL HEALTH LITERACY AND DIABETES MELLITUS: EXPERIENCE REPORT IN A STUDY GROUP | HAIDELUCIA RODRIGUES VIEIRA JAVARINI |
| 25017 | DIMETHYLTRYPTAMINE AND HARMINE, COMPONENTS OF AYAHUASCA, ISOLATED AND IN COMBINATION, DECREASED COCAINE-INDUCED APOPTOSIS IN SHSY-5Y CELLS | GABRIELA SALLES DOS SANTOS |
| 25016 | UNIVERSITY PHARMACY: CONTRIBUTIONS TO THE PROMOTION OF THE RATIONAL USE OF MEDICINES | ELAINE GOMES DA SILVA |
| 25015 | ALGORITHMS FOR CLINICAL PRACTICE IN UNIVERSITY PHARMACY: STRATEGY TO PROMOTE THE PROPER USE OF MEDICINAL PLANTS AND HERBAL MEDICINES | CARLOS NÔ BISPO |
| 25014 | PRODUCTION OF HEALTH EDUCATION VIDEOS FOR DEAF PEOPLE: A BIBLIOMETRIC STUDY | STHEFANY BRITO SALOMAO |
| 25013 | LITERACY FOR SELF-CARE AND SELF-MEDICATION IN SOLVING SELF-LIMITING PROBLEMS FOR COMMUNITY HEALTH AGENTS (CHA) IN THE MUNICIPALITY OF ARARAQUARA-SP | HELOISA LAURINDO DE MENDONCA |
| 25012 | FACTORS ASSOCIATED WITH SELF-REPORTED DEPRESSION DISORDERS AMONG TEACHERS IN ESPÍRITO SANTO | BRUNA LOPES ANTONUCCI |
| 25011 | FACTORS ASSOCIATED WITH THE STIGMA OF PEOPLE LIVING WITH HIV ATTENDED AT A UNIVERSITY HOSPITAL IN SOUTHEAST BRAZIL | RUTHIELI SANTOS NEVES |
| 25010 | PROJECT-BASED LEARNING: A STRATEGY FOR TEACHING EPIDEMIOLOGY AND SOLVING REAL-WORLD PROBLEMS | LETÍCIA GUEDES MORAIS GONZAGA DE SOUZA |
| 25009 | ANALYSIS OF THE PROFILE OF DRUG-DRUG INTERACTIONS IDENTIFIED IN NEONATES UNDER INTENSIVE CARE | NATHALIA BEATRIZ DE OLIVEIRA PEDROSA |
| 25007 | INTEGRATION OF PHARMACOLOGY, CLINICAL PHARMACY AND PHARMACEUTICAL CARE IN THE MULTIDISCIPLINARY APPROACH TO THROMBOSIS | AWDREY LUCY FLAUZINO DOS REIS |
| 25006 | CLINICAL TELECONSULTATIONS TO SUPPORT PRIMARY HEALTH CARE PHARMACISTS | JORGIANE APARECIDA FIGUEIREDO SANTOS |
| 25005 | SUCCESSFUL EXPERIENCE OF IMPLEMENTING PHARMACEUTICAL CONSULTATIONS AT THE DOCTOR PLINIO PRADO COUTINHO OUTPATIENT OF ALFENAS-MG | FERNANDA PIMENTEL DE LIMA |
| 25004 | HORMONE THERAPY FOR BREAST CANCER AND CONCOMITANT USE OF MEDICATIONS: A LIVED EXPERIENCE OF AMBIGUITY | MARIANNA CARDOSO DE ARAUJO SOUZA |
| 25001 | TOWARDS AN EMBODIED HEALTH EDUCATION | RENATA LOPES SERRA NEGRA |
| 25000 | PROVISION OF HEALTH EDUCATION SERVICE TO PROMOTE PREVENTION AND MANAGEMENT OF CHRONIC DISEASES | LUMA TELES VITALE |
| 24999 | REVEALING POWER RELATIONS IN INTERPROFESSIONAL EDUCATION | KIRLA BARBOSA DETONI |
| 24997 | EVALUATION OF ADVERSE DRUG REACTIONS IN THE ONCOLOGY SECTOR OF SANTA DE ALFENAS-MG | LETÍCIA DE OLIVEIRA MARUSSO |
| 24996 | SYMPTOMS OF INSOMNIA AMONG SCHOOL TEACHERS IN ESPÍRITO SANTO: A CROSS-SECTIONAL STUDY | YOHAN CANCILHERI MAZZINI |
| 24994 | DRUG FACILITATED CRIME: A BIBLIOGRAPHICAL REVIEW | DANIELLA SALLES MARCOLINO |
| 24993 | ADVERSE DRUG EVENTS INVOLVING OLDER PEOPLE REPORTED IN OFFICIAL REPORTING SYSTEMS: AN INTEGRATIVE REVIEW | GABRIELA OLIVEIRA BUZELIN DORIA |
| 24990 | EVALUATION OF THE NEUROPROTECTIVE EFFECT OF DIMETHYLTRYPTAMINE AND HARMINE, COMPONENTS OF AYAHUASCA, ISOLATED AND IN COMBINATION, AGAINST ETHANOL-INDUCED NEUROTOXICITY | LUANA YURI YAMASHITA |
| 24988 | INTERVENTIONS IN PATIENTS SERVED IN A PHARMACEUTICAL OFFICE IN A UNIVERSITY PHARMACY IN THE SOUTH OF MINAS GERAIS. | ALINE KARINA MAURE |
| 24987 | IMPACT OF GENETIC VARIANTS IN CYTOCHROME P450 ENZYMES ON THE RESPONSE TO CLOZAPINE IN REFRACTORY SCHIZOPHRENIA | MARILIA APARECIDA BATISTA DOS SANTOS |
| 24985 | RESULTS OF PHARMACEUTICAL ACTIVITIES IN THE MANAGEMENT OF PAIN IN ONCOLOGICAL PATIENTS: INTEGRATIVE REVIEW | MICHELLE CANCADO ARAUJO BARROS |
| 24982 | CHARACTERIZATION OF THE MEDICATION PROFILE CONTAINED IN THE 2023 BEERS CRITERIA UPDATE IN A PUBLIC HIGH COMPLEXITY HOSPITAL | RAFAEL SILVA DE ARRUDA |
| 24981 | ACOMPANHAMENTO FARMACOTERAPÊUTICO A PACIENTES COM DIABETES MELLITUS TIPO 2 NA ATENÇÃO PRIMÁRIA À SAÚDE | BRENDA MARIA NICÁCIA DA SILVA |
| 24977 | MENTAL DISORDERS IN OBESE PATIENTS TREATED IN PUBLIC HEALTH SERVICES | ROSE MEIRE COSTA |
| 24976 | THE MULTIPLE VIOLENCES EXPERIENCED BY PHARMACISTS IN THE WORKPLACE | ELAINE CRISTINA COELHO BAPTISTA |
| 24974 | DETECTION OF ADVERSE DRUG EVENTS IN THE OLDER POPULATION THROUGH THE APPLICATION OF TRIGGER TOOLS: ASPECTS FOR THEIR INCORPORATION INTO CLINICAL PRACTICE | GEOVANA SCHIAVO |
| 24972 | ENSURING THE EFFECTIVENESS OF WARFARIN TREATMENT: A CASE REPORT | JOSIANE COSTA DE SÁ |
| 24970 | INTERCULTURALITY IN HEALTH AS A PROPOSAL FOR DEVELOPING VALUES AND ETHICS IN PHARMACEUTICAL CARE: A TEACHING INTERNSHIP EXPERIENCE | JÉSSICA ALINE SILVA SOARES |
| 24968 | CHARACTERIZATION AND CLINICAL IMPACT OF THE DRUG-DRUG INTERACTION METHYLDOPA/FERROUS SULFATE IN HOSPITALIZED HIGH-RISK PREGNANT WOMEN | GABRIELA SANTANA OLIVEIRA |
| 24967 | CLINICAL IMPACT OF DRUG-DRUG INTERACTIONS INVOLVING SCOPOLAMINE IN HOSPITALIZED HIGH-RISK PREGNANT WOMEN | GABRIELA SANTANA OLIVEIRA |
| 24966 | CLINICAL CASE DISCUSSION BETWEEN RESIDENT PHARMACIST AND PRECEPTORY DURING PHARMACEUTICAL CONSULTATION IN A TERTIARY TEACHING HOSPITAL | ANA CAROLINA GODONHOTO SERAFIM |
| 24965 | EXPERIENCE IN CARING FOR THE OLDER PEOPLE WITH DEMENTIA IN THE HOME ENVIRONMENT: A QUALITATIVE SYNTHESIS OF EVIDENCE | MARIA GABRIELA MARTINS CRUZEIRO |
| 24963 | PROPOSAL FOR ANALYSIS OF PHARMACOTHERAPY AND MANAGEMENT IN A LONG-TERM CARE INSTITUTION: AN EXPERIENCE REPORT | BIANCA VERNIZZI SILVA |
| 24962 | PARTICIPATION OF A PHARMACEUTICAL RESIDENCE IN THE INTERDISCIPLINARY HOME VISIT | CLAUDIA MARIA MORAES SILVA |
| 24961 | PHARMACISTS? ROLE IN VULVOVAGINAL CANDIDIASIS CARE IN MINAS GERAIS | THAÍS TARGINO FERREIRA LACERDA |
| 24959 | PHARMACEUTICAL CONSULTANTS IN THE SUS OF ALFENAS | FERNANDA PIMENTEL DE LIMA |
| 24954 | INSTRUMENTS TO MEASURE PATIENT SATISFACTION WITH COMPREHENSIVE MEDICATION MANAGEMENT SERVICES: A SCOPING REVIEW | LORAYNE CAROLINE RESENDE |
| 24953 | ADVERSE DRUG EVENTS INVOLVING ANTINEOPLASTIC MEDICINES REPORTED ON THE BRAZILIAN HEALTH SURVEILLANCE NOTIFICATION SYSTEM (VIGIMED) | JULIANA DE OLIVEIRA GOMES RAMOS |
| 24952 | TRAINING ON THE IMPLEMENTATION OF THE HOSPITAL INFECTION CONTROL COMMITTEE IN THE HOSPITAL ENVIRONMENT | AMANDA ELISA ALVES MARQUES SILVA |
| 24951 | DISCUSSION OF SCIENTIFIC ARTICLES IN CENTRO DE ESTUDOS DO MEDICAMENTO (CEMED): A TEACHING EXPERIENCE REPORT | URI FLEGLER VIEIRA MACHADO |
| 24949 | CLINICAL RESULTS OF PATIENTS WITH TYPE 2 DIABETES MELLITUS FOLLOWED BY THE COMPREHENSIVE MEDICATION MANAGEMENT SERVICE IN PRIMARY HEALTH CARE | CELIO REZENDE LARA JUNIOR |
| 24948 | CENTRO DE ESTUDOS DO MEDICAMENTO (CEMED): FROM INFORMATION REQUESTS TO THE PROMOTION OF RATIONAL USE OF MEDICINES | VICTOR GUILHERME BATISTA FREITAS |
| 24947 | PATIENT AS EDUCATOR IN THE TRAINING OF PHARMACEUTICAL PROFESSIONALS: A RELEVANT TEACHING APPROACH? | BRENDA HELOISE DE OLIVEIRA FRAGA |
| 24946 | PROFILE OF ANTIMICROBIALS USE FOR MANAGEMENT PHARYNGOTONSILLITIS AMONG PHARMACY STUDENTS | ALINE SILVA DE ASSIS SANTOS |
| 24945 | PHARMACEUTICAL CARE AIMED AT THE USER OF RADIOPHARMACEUTICALS: A INTEGRATIVE REVIEW | LIDIA FREITAS FONTES |
| 24943 | VIOLENCE AGAINST WOMEN PHARMACISTS: A DESCRIPTIVE STUDY | ALINE SILVA DE ASSIS SANTOS |
| 24942 | PHARMACEUTICAL GUIDANCE ON WOMEN?S COMPREHENSIVE HEALTH: WHO PROVIDES IT? | EMMANUELLE EDUARDA NERY VIEIRA |
| 24941 | USE OF OPIOIDS ASSOCIATED WITH LAXANTS IN PALLIATIVE CARE: A CASE REPORT | MARIA FERNANDA CARVALHO RIBEIRO |
| 24939 | ADVERSE DRUG EVENTS INVOLVING BIOLOGICAL MEDICINES USED TO TREAT REUMATHOID ARTHRITIS REPORTED IN OFFICIAL REPORTING SYSTEMS: AN INTEGRATIVE REVIEW | PAULO VITOR ROZARIO DA SILVA |
| 24938 | IDENTIFIABILITY AND TRACEABILITY OF BIOLOGICAL MEDICINES USED IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN SUSPECTED ADVERSE DRUG EVENTS REPORTED IN VIGIMED | PAULO VITOR ROZARIO DA SILVA |
| 24937 | RATIONAL USE OF MEDICINES: TRAINING OF COMMUNITY HEALTH AGENTS | MAYARA DE ALMEIDA LIMA RIBEIRO |
| 24933 | INCIDENTS OF VIOLENCE AGAINST WOMEN FROM THE PERSPECTIVE OF PHARMACISTS: A DESCRIPTIVE STUDY | AGHATA SCARLETT DE ASSIS VIEIRA |
| 24931 | ASPECTS INVOLVED IN THE SUSTAINABILITY OF THE COMPREHENSIVE MEDICATION MANAGEMENT SERVICES | ALINE ANGÉLICA DE SOUZA VALENTIN |
| 24930 | ADVERSE DRUG EVENTS INVOLVING OPIOIDS REPORTED ON THE BRAZILIAN HEALTH SURVEILLANCE NOTIFICATION SYSTEM (VIGIMED) | GABRIELA DE PAULA GUIMARAES RODRIGUES |
| 24929 | ADVERSE DRUG EVENTS AMONG OLDER ADULTS IN BRAZIL BEFORE AND AFTER THE ONSET OF THE COVID-19 PANDEMIC | CRISTIANE DE PAULA REZENDE |
| 24928 | ANTIMICROBIALS AND ANTIPARASITICS SELF-MEDICATION BY UNIVERSITY STUDENTS DURING THE COVID-19 PANDEMIC: A SCOPING REVIEW | LARISSA TORRES FERNANDES |
| 24927 | QUALIFYING THE MEDICATION SYSTEM IN A LONG-TERM CARE FACILITY FOR OLDER ADULTS: A HYBRID EFFECTIVENESS-IMPLEMENTATION STUDY | ANA LUDMILA SANTOS PLAUSKA |
| 24926 | PATIENTS? EXPERIENCE WITH PHARMACOLOGICAL TREATMENT OF RHEUMATOID ARTHRITIS: A QUALITATIVE SYNTHESIS OF EVIDENCE | CRISTIANE DE PAULA REZENDE |
| 24922 | EDUCATION IN PHARMACOVIGILANCE AS A TOOL IN CONSOLIDATION OF THE KNOWLEDGE OF HEALTH PROFESSIONALS | DANIELLE APARECIDA FERREIRA DE OLIVEIRA MARRAFON |
| 24921 | PALLIATIVE CARE: PROFILE OF PATIENTS SERVED AT SANTA CASA DE ALFENAS-MG | EMANUELLE GONCALVES GARDONA DE RESENDE |
| 24919 | PROBLEMS RELATED TO MEDICATIONS IN CHRONIC PATIENTS CONSULTING IN A FAMILY HEALTH UNIT | PATRICIA VERA RODRIGUEZ |
| 24916 | CHARACTERIZATION OF MEDICINES WITH SUSPECTED ADVERSE REACTIONS USED IN INPATIENTS IN A PUBLIC HOSPITAL IN PARAGUAY | IRMA RAMIREZ |
| 24915 | APPLICATION OF A SELF-ASSESSMENT QUESTIONNAIRE ON THE MANAGEMENT OF MEDICATION INFORMATION AS A KEY FACTOR FOR PATIENT SAFETY IN TWO PUBLIC HEALTH CARE CENTERS IN PARAGUAY | PATRICIA GUADALUPE ACOSTA RECALDE |
| 24915 | CHARACTERIZATION OF THE MEDICATION PROFILE CONTAINED IN THE 2023 BEERS CRITERIA UPDATE IN A HIGH COMPLEXITY HOSPITAL | RAFAEL SILVA DE ARRUDA |
| 24911 | UTILIZATION OF THE STRUCTURED OBJECTIVE CLINICAL EXAMINATION IN A VACCINATION COURSE WITHIN THE PHARMACY UNDERGRADUATE PROGRAM: AN EXPERIENCE REPORT | CARLOS EDUARDO DE OLIVEIRA PEREIRA |
| 24910 | DEVELOPMENT AND CONTENT VALIDATION OF AN INSTRUMENT FOR ACTIVE SEARCH OF SUSPECTED ADVERSE DRUG REACTION | ANA CLARA GARCIA MARTON |
| 24908 | USE OF MEDICINAL PLANTS BY ELDERLY DURING THE COVID-19 PANDEMIC | PATRÍCIA SILVA BAZONI |
| 24907 | FACTORS ASSOCIATED WITH NON-ADHERENCE TO PHARMACOTHERAPY IN RESIDENTS OF THE SOUTH REGION OF ESPÍRITO SANTO | PATRÍCIA SILVA BAZONI |
| 24879 | IMPACT OF PROLONGED USE OF PHENOBARBITAL ON THE BIOMECHANICS OF RATS FEMURS | RICHYELLEN BARROS BUCKER |
Los resúmenes aprobados se publicarán más tarde esta noche (17/05).
Todos deben enviar sus banners utilizando el modelo a continuación. El texto puede estar en inglés, portugués o español. No hay un tamaño ni tipo de fuente definido.
Debe enviarse por correo electrónico (cientifica.sicf@gmail.com) antes del día 20 de mayo a las 17 horas.
Aclarando algunas dudas:
Para la presentación oral se elegirán las 8 mejores puntuaciones. Para que los resúmenes sean incluidos en los anales, deben tener un promedio de 6. Aquellos que no presenten oralmente igualmente serán publicados en la Revista BJHP. Todos los resúmenes aprobados deben formar parte del banner. Esto se publicará en una aplicación de eventos.
PLANTILLA DEL BANNER haga clic Banner simpósio
Es obligatorio que al menos 1 autor esté registrado en el Simposio, ANTES DEL ENVÍO DE LA OBRA. La inscripción da derecho a la presentación de hasta 02 obras.
Envíe el resumen del trabajo en línea según el modelo, identificado con el (los) nombre (s) del (los) autor (es), a través del sitio web de UNIFAL, ambiente CAEX. Cada trabajo tendrá un máximo de 15 autores. Incluir los nombres de los autores en el CAEX ya que el certificado se emite automáticamente. Los certificados no serán corregidos después de su emisión por falta de inclusión de los autores en el sistema CAEX.
Texto: incluyendo título, autores, instituciones involucradas, indicación de la ayuda o subvención, que no debe exceder una página, con un margen superior izquierdo de 2 cm y un margen derecho e inferior de 1,5 cm en papel A4.
Fuente “Times New Roman” – tamaño 11, espacio simple.
Título: en mayúsculas, centrado y en negrita.
Autores: sin negrita, escritos en orden directo (nombre y apellido, completos y sin abreviaturas).
Instituciones involucradas: en minúsculas, enumerando el(los) autor(es) con número(s), cuando se trate de más de una Institución o Departamento (Universidad).
Espacio: sencillo. Entre título, autores, Departamento/Institución y texto, dejar una línea en blanco.
Indicar al final del texto, sólo ayuda económica. Cuando haya más de una agencia financiadora, sepárelas con un punto y coma.
Los resúmenes deben ser escritos en inglés de manera continua, sin subítems, presentando: Introducción (con objetivo), Método, Resultados (originales que contribuyan al conocimiento y desarrollo de las Ciencias Farmacéuticas, cualitativos cuando corresponda) y Conclusión.
Se pueden aceptar resúmenes de estudios cualitativos y/o cuantitativos, ya sean experimentales, observacionales o de revisión (narrativa, integradora o sistemática). Informe de experiencia docente didáctica (participación obligatoria de un docente); Informe de experiencia del estudiante en la docencia o estudios de posgrado (participación obligatoria del estudiante); resultados de investigaciones científicas; Informe de experiencia profesional exitosa; Relato del caso; Relato de serie de casos.
Los resúmenes deben enviarse en formato .doc o .docx. Después de la corrección del mismo por un revisor inglés, si es necesario, enviaremos el mismo para su corrección y reconocimiento del autor que hizo el envío.
Notas importantes:
Los resúmenes deben estar escritos de forma clara, sin errores ortográficos ni gramaticales, y dentro del formato descrito en las bases, de lo contrario serán rechazados.
No se aceptarán resúmenes que contengan únicamente propuestas de trabajo o que se envíen fuera de las especificaciones anteriores.
Trabajos relacionados con investigaciones que involucren seres humanos – las investigaciones que, individual o colectivamente, directa o indirectamente involucren seres humanos, en su totalidad o en parte, incluyendo el manejo de información o materiales, deben seguir las determinaciones de la Resolución 466/2012 de la Comisión Nacional Consejo de Salud (CSN). Mencione el número de protocolo de aprobación en el resumen.
Solo se aceptarán resúmenes enviados a través del sitio web – CAEX, consulte el tutorial disponible en: https://www.unifal-mg.edu.br/simposiocuidadofarmaceutico/tutorial-para-submissao-de-resumos/.
Todos los resúmenes aprobados serán publicados en el suplemento de una revista científica por definir.
ATENCIÓN
Los autores deberán presentar los resúmenes de sus trabajos siguiendo estrictamente las “NORMAS PARA EL REGISTRO DE OBRAS CIENTÍFICAS” (ver modelo), elaboradas por el Comité Organizador del evento. La decisión del Comité Científico en la aprobación y adjudicación de los trabajos se considerará inapelable.
Los cinco mejores resúmenes recibirán una Mención de Honor en la ceremonia de clausura del evento.
Presentación oral y Mención de Honor:
Los mejores resúmenes serán seleccionados por los revisores y el Comité Científico para su presentación oral en una sesión virtual o para recibir una Mención de Honor. Los autores de los trabajos seleccionados para Presentación Oral serán comunicados vía e-mail. Cada autor tendrá 10 minutos para presentar y otros 5 minutos para responder la pregunta. La presentación (layout) es libre.
A su vez, los resúmenes seleccionados para Mención Honorífica serán anunciados en la Ceremonia de cierre.
Áreas temáticas de los resúmenes:
- Dispensación
- Orientación farmacéutica
- Formulación Magistral y Atención Farmacéutica
- Uso racional de medicamentos.
- Farmacoepidemiología, Farmacovigilancia y Seguridad del Paciente
- Prescripción farmacéutica
- Seguimiento farmacoterapéutico o manejo de la farmacoterapia
- Educación para la salud
- Farmacia Hospitalaria
- Temas de interés en salud pública
- Experiencia didáctica
PLANTILLA DE RESUMEN: modelo-resumo-simposio-2024
Enviar el banner hasta 20/05 por email (cientifica.sicf@gmail.com) hasta 17 horas (horario de Brasilia)
Si tiene alguna pregunta, comuníquese con el Comité Científico del IX Simposio Internacional de Atención Farmacéutica al correo electrónico: cientifica.sicf@gmail.com.